Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Mar;39(3):261–263. doi: 10.1111/j.1365-2125.1995.tb04446.x

The effect of inhaled and oral dextromethorphan on citric acid induced cough in man.

T J Grattan 1, A E Marshall 1, K S Higgins 1, A H Morice 1
PMCID: PMC1365001  PMID: 7619666

Abstract

1. Dextromethorphan is a widely used antitussive agent which is a non-narcotic codeine analogue. We have investigated whether inhaled administration of dextromethorphan provides antitussive activity in a citric acid induced cough model. 2. Twenty normal subjects underwent repeated cough challenge with 5% citric acid. Subjects were studied on six occasions. Study medication consisted of oral dextromethorphan 30 mg or oral matched placebo or 1, 3 and 30 mg inhaled dextromethorphan or matched inhaled placebo. Cough challenge was administered 10 min after study medication and hourly thereafter up to 250 min. 3. No significant differences were seen between baseline cough responses. Oral dextromethorphan (30 mg) produced a mean percentage reduction in cough of 38% (P < 0.002), which remained significant at 250 min. Inhaled dextromethorphan had no clinically significant effect although activity at later time points was not excluded. The antitussive effect of oral dextromethorphan is confirmed with prolonged inhibition of induced cough. It is possible that dextromethorphan or its active metabolites act centrally to inhibit the cough reflex.

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand Kumar T. C., David G. F., Sankaranarayanan A., Puri V., Sundram K. R. Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4185–4189. doi: 10.1073/pnas.79.13.4185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BENSON W. M., STEFKO P. L., RANDALL L. O. Comparative pharmacology of levorphan, racemorphan and dextrorphan and related methyl ethers. J Pharmacol Exp Ther. 1953 Oct;109(2):189–200. [PubMed] [Google Scholar]
  3. BICKERMAN H. A., GERMAN E., COHEN B. M., ITKIN S. E. The cough response of healthy human subjects stimulated by citric acid aerosol. II. Evaluation of antitussive agents. Am J Med Sci. 1957 Aug;234(2):191–206. doi: 10.1097/00000441-195708000-00010. [DOI] [PubMed] [Google Scholar]
  4. CASS L. J., FREDERIK W. S. Quantitative comparison of cough-suppressing effects of romilar and other antitussives. J Lab Clin Med. 1956 Dec;48(6):879–885. [PubMed] [Google Scholar]
  5. Callaway J. K., King R. G., Boura A. L. Evidence for peripheral mechanisms mediating the antitussive actions of opioids in the guinea pig. Gen Pharmacol. 1991;22(6):1103–1108. doi: 10.1016/0306-3623(91)90585-t. [DOI] [PubMed] [Google Scholar]
  6. Dixon R., Carbone J. J., Mohacsi E., Perry C. Dextromethorphan: radioimmunoassay and pharmacokinetics in the dog. Res Commun Chem Pathol Pharmacol. 1978 Nov;22(2):243–255. [PubMed] [Google Scholar]
  7. Empey D. W., Laitinen L. A., Young G. A., Bye C. E., Hughes D. T. Comparison of the antitussive effects of codeine phosphate 20 mg, dextromethorphan 30 mg and noscapine 30 mg using citric acid-induced cough in normal subjects. Eur J Clin Pharmacol. 1979;16(6):393–397. doi: 10.1007/BF00568199. [DOI] [PubMed] [Google Scholar]
  8. Fuller R. W., Karlsson J. A., Choudry N. B., Pride N. B. Effect of inhaled and systemic opiates on responses to inhaled capsaicin in humans. J Appl Physiol (1985) 1988 Sep;65(3):1125–1130. doi: 10.1152/jappl.1988.65.3.1125. [DOI] [PubMed] [Google Scholar]
  9. Karlsson J. A., Lanner A. S., Persson C. G. Airway opioid receptors mediate inhibition of cough and reflex bronchoconstriction in guinea pigs. J Pharmacol Exp Ther. 1990 Feb;252(2):863–868. [PubMed] [Google Scholar]
  10. Larrey D., Amouyal G., Tinel M., Letteron P., Berson A., Labbe G., Pessayre D. Polymorphism of dextromethorphan oxidation in a French population. Br J Clin Pharmacol. 1987 Nov;24(5):676–679. doi: 10.1111/j.1365-2125.1987.tb03230.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lewis R. A., Fleming J. S. Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler. Br J Dis Chest. 1985 Oct;79(4):361–367. doi: 10.1016/0007-0971(85)90069-5. [DOI] [PubMed] [Google Scholar]
  12. Morice A. H., Higgins K. S., Yeo W. W. Adaptation of cough reflex with different types of stimulation. Eur Respir J. 1992 Jul;5(7):841–847. [PubMed] [Google Scholar]
  13. Musacchio J. M., Klein M. Dextromethorphan binding sites in the guinea pig brain. Cell Mol Neurobiol. 1988 Jun;8(2):149–156. doi: 10.1007/BF00711241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ramachander G., Williams F. D., Emele J. F. Determination of dextrorphan in plasma and evaluation of bioavailability of dextromethorphan hydrobromide in humans. J Pharm Sci. 1977 Jul;66(7):1047–1048. doi: 10.1002/jps.2600660740. [DOI] [PubMed] [Google Scholar]
  15. Sakane T., Akizuki M., Yamashita S., Nadai T., Hashida M., Sezaki H. The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug. Chem Pharm Bull (Tokyo) 1991 Sep;39(9):2456–2458. doi: 10.1248/cpb.39.2456. [DOI] [PubMed] [Google Scholar]
  16. Zhang Y., Britto M. R., Valderhaug K. L., Wedlund P. J., Smith R. A. Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6. Clin Pharmacol Ther. 1992 Jun;51(6):647–655. doi: 10.1038/clpt.1992.77. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES